Dr. Janjigian on Immunotherapy Combinations in Gastric CancerOncLiveData for checkpoint inhibitors has opened the field of immunotherapy in gastric cancer. Now that the field has made this leap, physicians are trying to understand how it fits with the … Continue reading
Early-stage SA biotech developing new uses for stem cell technology, including organ transplantsSan Antonio Business JournalA San Antonio-based, developmental-stage research company is looking to use stem cell technology in new ways, including as a mea… Continue reading
Genetic Engineering & Biotechnology NewsSupplement: Novel Cancer Immunotherapy CombosGenetic Engineering & Biotechnology NewsImmunotherapy drugs, such as antibodies, make cancer cells more vulnerable to destruction by T cells. The leading immunotherapy… Continue reading
Supplement: Cancer Immunotherapies Development BarriersGenetic Engineering & Biotechnology NewsOver the past century, a greater understanding of how our immune system recognizes and targets foreign invaders for destruction has emerged, resulting in can… Continue reading
Genetic Engineering & Biotechnology News |
Supplement: Who Gets Immunotherapy for Cancer?
Genetic Engineering & Biotechnology News Immunotherapy is an emerging field, and scientists are still learning how a patient’s immune repertoire and target profile translate to progression-free survival or disease remission. The immuno-oncology biomarkers, and companion diagnostics track at … Loncar Cancer Immunotherapy ETF – Receive News & Ratings DailyFrisco Fastball Cancer Immunotherapy Market Experts Share 2016 Highlights, 2024 PredictionsEdition of Analyst |